FDG Triple Phase PET CT

Patients with suspected or known cancers where routine **Positron Emission Tomography CT findings are inconclusive or borderline. Individuals requiring differentiation between tumor recurrence and post-treatment changes after surgery, chemotherapy, or radiotherapy. Cases where distinction between malignant and inflammatory lesions is needed using